Skip to main content
. 2019 Mar 3;10(7):1616–1621. doi: 10.7150/jca.28218

Figure 1.

Figure 1

Prohibitin overexpresses in endometrial cancer and associates with poor prognosis. The expression of prohibitin in benign and endometrial cancer tissues was assessed using IHC staining. (A) Representative images were captured at 200× magnification. (B) Prohibitin IHC scores in endometrial lesion tissues are presented. (C, D) The overall survival and disease-free survival curves of endometrial cancer patients with different levels of prohibitin expression in 24 tissue samples of endometrial cancer. (E) Prohibitin expression correlated with serum CA125 level. *, p<0.05.